About GOCART

What is gocart?

GoCART is a multi-stakeholder coalition in the field of gene and cellular therapies manufactured from cells and tissues of hematopoietic origin. 

approach

The GoCART Coalition is guided by a clear mission, vision and a set of values.

 

 

founders

The Coalition was founded by The EHA and the EBMT, the two leading European societies in the field of haematology and stem cell transplantation.

 

Our Team

Chiara Bonini

University Vita-Salute San Raffaele, Milan, Italy

Christian Chabannon

Aix-Marseille Université School of Medicine & Institut Paoli-Calmettes Comprehensive Cancer Center. Marseille. France

Julio Delgado

Hospital Clínic de Barcelona, FRCB-IDIBAPS, Universitat de Barcelona, Spain

Martin Dreyling

Medizinische Klinik III, Klinikum der Universität, LMU München, Germany

Jurgen Kuball

University Medical Center Utrecht, The Netherlands

Tuula Rintala

EBMT, Barcelona, Spain

Annalisa Ruggeri

IRCCS San Raffaele Scientific Institute, Milano, Italy

Anna Sureda

Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain

Project management

Andrea Egan

GoCART Project Manager - EBMT

Yolanda Cabrerizo

GoCART Project Manager - EHA

What is GoCART?

GoCART is a multi-stakeholder coalition in the field of gene and cellular therapies manufactured from cells and tissues of hematopoietic origin. The Coalition was launched in 2020 and brings together stakeholders from across the sector, including patients, health care professionals, health authorities, Health Technology Assessment (HTA) bodies and reimbursement agencies, pharmaceutical companies and medical non-profit organisations

GoCART’s aim is to promote patient access to novel cellular therapies and to contribute health and well-being through innovation by multi-stakeholder collaboration on clinical data, standards of care, centre qualification, education and policy. 

Approach

Our values

Our mission

Our mission is to promote patient access to novel cellular therapies and to contribute to health and well-being through innovation by multi-stakeholder collaboration on clinical data, standards of care, centre qualification, education and policy.

Our vision

Our vision is to be a trusted partner and a leading force in the field of cellular therapies at national and international levels.

Founders

The EBMT is a non-profit medical and scientific organisation established in 1974 which hosts a unique patient registry providing a pool of data to perform studies and assess new trends. We aim to be the connection between patients, researchers and other stakeholders to anticipate the future of cellular and stem cell-based therapies. Our community of healthcare professionals is focused on innovation, research and the advancement of these fields to save and improve the lives of patients with blood-related disorders. Visit ebmt.org to learn more about membership, the Joint Accreditation Committee, International Society of Cellular Therapy-Europe & EBMT (JACIE) qualification scheme, educational opportunities and how to get involved.

The European Hematology Association (EHA) promotes excellence in patient care, research, and education in hematology. We serve medical professionals, researchers, and scientists with an active interest in hematology. We are proud to be the largest European-based organization connecting hematologists worldwide to support career development and research, harmonize hematology education, and advocate for hematologists and hematology.